Your browser doesn't support javascript.
loading
Author Correction: DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance.
Schröder, Martin; Renatus, Martin; Liang, Xiaoyou; Meili, Fabian; Zoller, Thomas; Ferrand, Sandrine; Gauter, Francois; Li, Xiaoyan; Sigoillot, Frederic; Gleim, Scott; Stachyra, Therese-Marie; Thomas, Jason R; Begue, Damien; Khoshouei, Maryam; Lefeuvre, Peggy; Andraos-Rey, Rita; Chung, BoYee; Ma, Renate; Pinch, Benika; Hofmann, Andreas; Schirle, Markus; Schmiedeberg, Niko; Imbach, Patricia; Gorses, Delphine; Calkins, Keith; Bauer-Probst, Beatrice; Maschlej, Magdalena; Niederst, Matt; Maher, Rob; Henault, Martin; Alford, John; Ahrne, Erik; Tordella, Luca; Hollingworth, Greg; Thomä, Nicolas H; Vulpetti, Anna; Radimerski, Thomas; Holzer, Philipp; Carbonneau, Seth; Thoma, Claudio R.
Afiliação
  • Schröder M; Novartis Institutes for BioMedical Research, Basel, Switzerland. martin-1.schroeder@novartis.com.
  • Renatus M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Liang X; Ridgeline Discovery, Basel, Switzerland.
  • Meili F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Zoller T; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Ferrand S; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Gauter F; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Li X; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Sigoillot F; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Gleim S; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Stachyra TM; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Thomas JR; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Begue D; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Khoshouei M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Lefeuvre P; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Andraos-Rey R; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Chung B; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Ma R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Pinch B; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Hofmann A; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Schirle M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Schmiedeberg N; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Imbach P; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Gorses D; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Calkins K; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Bauer-Probst B; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Maschlej M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Niederst M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Maher R; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Henault M; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Alford J; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Ahrne E; Novartis Institutes for BioMedical Research, Cambridge, MA, USA.
  • Tordella L; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Hollingworth G; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Thomä NH; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Vulpetti A; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Radimerski T; Swiss Institute for Experimental Cancer Research (ISREC), École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Holzer P; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Carbonneau S; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Thoma CR; Ridgeline Discovery, Basel, Switzerland.
Nat Commun ; 15(1): 7109, 2024 Aug 19.
Article em En | MEDLINE | ID: mdl-39160182
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article